BMC Medicine

official impact factor 5.75

Open Access Highly Access Research article

The effects of cholesterol lowering with simvastatin on cause-specific mortality and on cancer incidence in 20,536 high-risk people: a randomised placebo-controlled trial [ISRCTN48489393]

Heart Protection Study Collaborative Group

BMC Medicine 2005, 3:6 doi:10.1186/1741-7015-3-6

No comments have yet been made on this article.

Post a comment